Home›Companies›Biotech & Pharma›QurAlis

QurAlis Corp

Updated Oct 27, 2026·Latest SEC filing Sep 5, 2025·Suggest an edit

About QurAlis

QurAlis is a private company based in Cambridge, Massachusetts. It has reported $118,157,598 raised in four offerings on Form D since May 2020.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 21, 2025Sep 5, 2025$19,952,387of $24.9M target19$1.0MDebt, Options, Convertible Promissory NotesRule 506(b)Form D ↗
Dec 20, 2022Mar 13, 2023$59,982,508of $88.0M target27$2.2MEquity, Shares of Series B-1, B-2 and B-3 Preferred StockRule 506(b)Form D ↗
Aug 12, 2022Sep 1, 2022$5,000,000of $10.0M target19$263KDebt, Options, Convertible Promissory NotesRule 506(b)Form D ↗
May 1, 2020May 18, 2020$33,222,703of $60.0M target25$1.3MEquity, Series A-1 Preferred Stock and Series A-2 Preferred StockRule 506(b)Form D ↗
Total, four offerings$118,157,598

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on QurAlis's Form D filed Sep 5, 2025.

SV
Shafique Virani
Executive officer
MH
JB
Jason Brown
Executive officer
AW
KR
Kasper Roet
Executive officer, director and promoter
KR
Kasper Roet
Executive officer, director and promoter
AS
Amy Schulman
Director
LD
Luc Dochez
Director
CK
Cillian King
Director

Earlier filings also listed Vikas Sharma (executive officer, last listed Mar 2023), Julio Vega (executive officer, last listed Mar 2023), Hagen Cramer (executive officer, last listed Mar 2023), Daniel Elbaum (executive officer, last listed Mar 2023), Chris Thomajan (executive officer, last listed Mar 2023), Angela Genge (executive officer, last listed Mar 2023), Roel Bulthuis (director, last listed Sep 2022) and Jonathan Behr (director, last listed Sep 2022).

Sources

  1. SECQurAlis Corp filing history